Renaissance Technologies - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 48 filers reported holding SCPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$569
-65.3%
55,886
-69.1%
0.00%
-50.0%
Q1 2023$1,642
+9.0%
180,986
-13.8%
0.00%0.0%
Q4 2022$1,506
-99.9%
209,986
+16.5%
0.00%0.0%
Q3 2022$1,175,000
+27.3%
180,286
-5.9%
0.00%
+100.0%
Q2 2022$923,000
-12.7%
191,586
+3.0%
0.00%0.0%
Q1 2022$1,057,000
+11.4%
186,086
-1.5%
0.00%0.0%
Q4 2021$949,000
-26.3%
188,986
-2.4%
0.00%
-50.0%
Q3 2021$1,287,000
-2.7%
193,586
-10.6%
0.00%0.0%
Q2 2021$1,323,000
+3.9%
216,486
+13.1%
0.00%0.0%
Q1 2021$1,273,000
-2.6%
191,386
-22.5%
0.00%
+100.0%
Q4 2020$1,307,000
-41.2%
247,086
-17.1%
0.00%
-50.0%
Q3 2020$2,221,000
-9.6%
298,079
-10.7%
0.00%0.0%
Q2 2020$2,456,000
+72.5%
333,686
+73.4%
0.00%
+100.0%
Q1 2020$1,424,000
+53.8%
192,486
+17.6%
0.00%0.0%
Q4 2019$926,000
+40.7%
163,677
+46.0%
0.00%0.0%
Q3 2019$658,000
+353.8%
112,131
+146.4%
0.00%
Q2 2019$145,00045,5000.00%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
5AM Venture Management, LLC 3,561,474$17,166,0004.25%
AIGH Capital Management LLC 1,346,724$6,491,0001.71%
Worth Venture Partners, LLC 335,985$1,784,0001.05%
Ikarian Capital, LLC 884,008$4,261,0000.78%
Orbimed Advisors 4,797,148$23,122,0000.42%
ARMISTICE CAPITAL, LLC 2,700,000$13,014,0000.23%
Sandy Cove Advisors, LLC 10,592$51,0000.05%
Belvedere Trading LLC 239,219$1,270,0000.04%
IPG Investment Advisors LLC 14,300$69,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,200$637,0000.02%
View complete list of SCPHARMACEUTICALS INC shareholders